Carson Wealth (CWM LLC)
EVMN

Carson Wealth (CWM LLC)’s Evommune Inc EVMN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161 Buy
+7
New +$158 ﹤0.01% 5547

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Carson Wealth (CWM LLC)'s EVMN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) opened a new position in Evommune Inc (EVMN) in Q1 2026: 7 shares worth $161. The stake represents ﹤0.01% of the portfolio and ranks #5547 among its holdings.

84 funds tracked by Wall St. Rank hold EVMN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 7 shares of Evommune Inc worth $161 as of Q1 2026.
  • Evommune Inc was a new Carson Wealth (CWM LLC) position in Q1 2026.
  • Evommune Inc made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5547 holding.
  • 84 funds tracked by Wall St. Rank held Evommune Inc as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.